List view / Grid view
Johnson & Johnson announced Phase III data demonstrating effective COVID-19…
Johnson & Johnson announced Phase III data demonstrating effective COVID-19 protection and an increase in protection with a booster dose.
Janssen announced US FDA approval of Invega Hayfera, the first…
Janssen announced US FDA approval of Invega Hayfera, the first and only twice-yearly treatment for adults with schizophrenia.
A Phase III clinical trial to evaluate J&J's COVID-19 vaccine…
A Phase III clinical trial to evaluate J&J's COVID-19 vaccine in multiple countries has enrolled its first patients.
